| Dr John Joseph Shigo Jr, MD | |
|
417 Scarburgh Way, Alexandria, VA 22312-6212 | |
| (301) 537-9850 | |
| (707) 539-5511 |
| Full Name | Dr John Joseph Shigo Jr |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Primary Care |
| Location | 417 Scarburgh Way, Alexandria, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124173976 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 0101042043 (Virginia) | Secondary |
| 363LP2300X | Nurse Practitioner - Primary Care | 010142043 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Joseph Shigo Jr, MD 417 Scarburgh Way, Alexandria, VA 22312-6212 Ph: (301) 537-9850 | Dr John Joseph Shigo Jr, MD 417 Scarburgh Way, Alexandria, VA 22312-6212 Ph: (301) 537-9850 |
News Archive
Today's headlines include stories previewing the market, policy and political implications of the Supreme Court' health ruling, which is due out on Thursday.
A new type of drug therapy that is currently being tested in Canada could significantly reduce the death rate caused by the deadliest form of stroke. According to the Canadian Heart and Stroke Foundation, new developments in stroke research make it more important than ever that Canadians recognize and react to the warning signs of stroke.
The SwitchTM programme, 'Switch what you Do, View, and Chew', has been shown to be capable of promoting children's fruit and vegetable consumption and lowering 'screen time'. Researchers writing in the open access journal BMC Medicine tested the programme and report that it offers promise for use in youth obesity prevention.
Depressed individuals with a tendency to ruminate on negative thoughts, i.e. to repeatedly think about particular negative thoughts or memories, show different patterns of brain network activation compared to healthy individuals, report scientists of a new study in Biological Psychiatry.
Mayo Clinic researchers will receive more than $3 million in a four-year grant from the National Human Genome Research Institute to translate recent genomic discoveries into tools for individualized medicine. Recent advances in the genetics of heart and blood vessel diseases will be integrated into electronic medical records so doctors can more accurately determine patients' risk of heart attacks, blood vessel diseases and adverse reactions to heart medications.
› Verified 5 days ago